LSE:IDOX.L 8 February 2026

June 21, 2026, 12:13 AM EDT. Qiagen disclosed that Goldman Sachs has accumulated a 2.87% stake through a combination of ordinary shares, call options, warrants, swaps, and convertible bonds. The position is held indirectly across multiple Goldman Sachs entities with both physical and cash settlements. This notable institutional holding could impact Qiagen's shareholder structure and market perception. Qiagen clarified it is not responsible for the accuracy of the Dutch Authority for the Financial Markets notification but highlighted the increased institutional interest. Qiagen, a global life sciences firm, trades on several exchanges including NYSE, boasting a $7.61 billion market cap and an average volume of over 2 million shares. Current analyst consensus rates Qiagen stock as Hold with a $36 price target.